Mary Van Heukelom goes ‘Above and Beyond' to help cancer survivors
DES MOINES, Iowa – Mary Van Heukelom believes everyone has a calling in life, and hers is all about helping cancer survivors thrive.
When exercising with Van Heukelom, get ready to work up a sweat.
Members in this total training class can handle it. Because even though they've survived the worst, they're being taught by the best.
'Everyone that's touched by cancer, if you say Mary Van Heukelom they know who you're talking about,' survivor Lynn Sandoval said.
'She just opened a whole of classes, a whole of opportunities for me to really feel like I could get back in shape and feel better about myself after treatment,' another survivor, Martha Gelhaus, said.
Van Heukelom has been working with cancer survivors for the past decade. Before that, she was a public school teacher.
'I consider myself still a teacher, still an educator,' Van Heukelom said. 'Now the topic is different and my audience is different.'
Iowa mom's remarkable impact on parents of kids with Down syndrome
An audience that completely changed her career path and life, all because of a transformational journey.
Back in 2011, Van Heukelom helped lead the original team of cancer survivors that went to Mount Everest Base Camp through Above and Beyond Cancer.
'I think the shift was the first time, the very first class I was able to teach and work with a group of cancer survivors,' Van Heukelom said. 'It was from day one, life-changing for me. There was a different element of energy and authenticity in that space that I had never experienced before in my life.'
After the trip, she was offered to be the program director at Above and Beyond; helping people after they survive cancer by connecting them to free fitness, nutrition, and wellness programs.
She leads some of the classes, but never expected what she did for work would become what she had to face in life.
'And it was in 2021, right after my 50th birthday, that I had my first cancer diagnosis and then a year later, my second cancer diagnosis,' Van Heukelom said. 'So, with both of those, a colon cancer and a breast cancer diagnosis, I felt that this has continue to enhance my understanding, of course, firsthand of the journey of a cancer survivor, which in turn I believe has allowed me to expand and deepen my compassion and my service to cancer survivors and the community.'
A community that's sometimes tough to be a part of, but one that's more bearable because of people like Mary Van Heukelom.
'She inspires me,' Gelhaus said. 'She makes me feel that I can do it, that I can push myself and I can achieve more than I thought I could.'
'She is my favorite person in the world. She literally saved my life,' Sandoval said. 'She's so inspirational. She's like my mom. I'm older than her and she's like my mom. She keeps me going and she's just so positive.'
Irma Ariza, a fashionista volunteer helping women Dress for Success every day
'We have our blood family and then we have our community of family, and I really believe in every person I've met as a part of my family and there are even people in this world that I haven't that that are part of the family of humanity,' Van Heukelom said. 'And so, if there's anything I can do in this space to make humanity better. That is my job.'
A job done by a mom, wife, and friend that many would say is remarkable.
'I want people to know that that I care about them,' Van Heukelom said. 'How we greet somebody matters. How we how we communicate with somebody matters. Again, it doesn't have to come with a title, a position, a role. It's about humanity and how we interact with the people around us. All matters.'
For Van Heukelom, it's just a way of living life. A gift she knows not to take for granted.
'I find it remarkable that I get to be here today. I find it remarkable that I have opportunities, and I know that I have been given opportunities that other people don't. And so that's where the remarkable is.'
Van Heukelom will head off on another transformational journey next month to Patagonia, Chile, with a team of 29 survivors and caregivers.
If you want to learn more about Above and Beyond Cancer, click here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
20 hours ago
- New York Times
Sacha Jenkins, Filmmaker Who Mined the Black Experience, Dies at 53
Sacha Jenkins, a fiery journalist and documentary filmmaker who strove to tell the story of Black American culture from within, whether in incisive prose explorations of rap and graffiti art or in screen meditations on Louis Armstrong, the Wu-Tang Clan or Rick James, died on May 23 at his home in the Inwood section of Manhattan. He was 53. The death was confirmed by his wife, the journalist and filmmaker Raquel Cepeda-Jenkins, who said the cause was complications of multiple system atrophy, a neurodegenerative disorder. Whatever the medium — zines, documentaries, satirical television shows — Mr. Jenkins was unflinching on the topic of race as he sought to reflect the depths and nuances of the Black experience as only Black Americans understood it. He was 'an embodiment of 'for us, by us,'' the journalist Stereo Williams wrote in a recent appreciation on Okayplayer, a music and culture site. 'He was one of hip-hop's greatest journalistic voices because he didn't just write about the art: He lived it.' And he lived it from early on. Mr. Jenkins, raised primarily in the Astoria section of Queens, was a graffiti artist as a youth, and sought to bring an insider's perspective to the culture surrounding it with his zine Graphic Scenes X-Plicit Language, which he started at 16. He later co-founded Beat-Down newspaper, which covered hip-hop; and the feisty and irreverent magazine Ego Trip, which billed itself as 'the arrogant voice of musical truth.' Want all of The Times? Subscribe.
Yahoo
a day ago
- Yahoo
Saudi Arabia's Non-Invasive Prenatal Testing (NIPT) Market Set to Triple by 2033: Developments, Strategies, and Financial Insights of Leading Players Eurofins Scientific, Roche, Invitae Corp., Illumina and More
Challenges remain, such as limited awareness and high costs, but initiatives under Vision 2030 aim to improve access and affordability Saudi Arabian Non-Invasive Prenatal Testing Market Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to offering. The Saudi Arabia Non-Invasive Prenatal Testing Market is expected to reach US$ 143.09 million by 2033 from US$ 46.33 million in 2024, with a CAGR of 13.35% from 2025 to 2033. Advances in technology, greater knowledge, better insurance coverage, safety, and the growing incidence of genetic abnormalities are the main factors propelling the non-invasive prenatal testing industry in Saudi Arabia. Recent developments in genetic testing technology and growing awareness among medical professionals and pregnant parents have propelled the non-invasive prenatal testing (NIPT) sector in Saudi Arabia. By screening for chromosomal disorders including Down syndrome, trisomy 18, and trisomy 13 by examining fetal DNA in a mother's blood sample, NIPT provides a safer option to conventional prenatal diagnostics like amniocentesis. For many pregnant women, NIPT is an attractive option due to its non-invasive nature and zero chance of miscarriage. As a result, NIPT is increasingly being used as the recommended screening method in prenatal treatment. The availability of cutting-edge diagnostic technologies and the growing emphasis on healthcare modernization are two major factors propelling NIPT's expansion in Saudi Arabia. Saudi Arabia has been making significant investments in its healthcare system as part of Vision 2030, which involves expanding access to cutting-edge medical technology. As a result of this emphasis on healthcare development, NIPT is now more widely available, with more clinics and hospitals implementing the technology to provide patients with a safe, accurate, and dependable prenatal screening choice. Additionally, pregnant moms now have better access to these essential therapies because of the government's initiatives to provide healthcare services throughout the whole nation. Another important element driving the use of NIPT in Saudi Arabia is growing knowledge of genetic abnormalities and the advantages of early prenatal screening, in addition to advances in healthcare and technology. The need for trustworthy prenatal diagnostics has increased due to the rising prevalence of congenital disorders and chromosomal abnormalities. The public and medical professionals are therefore increasingly cognizant of the significance of genetic testing. It is anticipated that this knowledge, together with enhanced insurance coverage and the expanding availability of NIPT, would continue to propel market expansion in Saudi Arabia. Saudi Arabia's NIPT sector is expected to grow further as NIPT technologies continue to progress and are included into routine prenatal treatment. Growth Drivers for the Saudi Arabia Non-Invasive Prenatal Testing MarketTechnological Advancements The precision and dependability of genetic screening have been greatly enhanced by technological developments in non-invasive prenatal testing (NIPT). More accurate fetal DNA analysis is made possible by advancements in next-generation sequencing (NGS) and bioinformatics, which make it possible to identify a wider variety of genetic disorders. These developments have given expecting parents and medical professionals a more thorough screening tool by extending NIPT's capabilities beyond common chromosomal diseases like Down syndrome, trisomy 18, and trisomy 13 to encompass microdeletions and single-gene disorders. Because it enables the earlier, safer, and more accurate diagnosis of any genetic disorders without the hazards associated with intrusive testing procedures, NIPT has become the preferred option in prenatal care due to the integration of sophisticated technology. Rising Maternal Age One major factor contributing to the rising need for non-invasive prenatal testing (NIPT) is the aging of mothers. The chance of genetic abnormalities like Down syndrome rises as more women, especially those over 35, put off having children. Because older women are more likely to seek out sophisticated prenatal screening alternatives like NIPT, this demographic change has resulted in a greater prevalence of pregnancies among these women. A safer, non-invasive substitute for conventional invasive testing, NIPT offers precise early genetic problem diagnosis without the dangers of amniocentesis or CVS. Pregnant women are choosing NIPT more frequently as a result of growing knowledge of these advantages, which is driving up demand for these secure and trustworthy prenatal screening techniques. High Prevalence of Genetic Disorders Genetic problems, such as Down syndrome and other chromosomal abnormalities, are very common in Saudi Arabia. The increasing need for trustworthy prenatal screening techniques, such non-invasive prenatal testing (NIPT), has been greatly influenced by this. Without the danger of miscarriage that comes with intrusive tests like amniocentesis, NIPT provides a safer, more reliable method of identifying genetic abnormalities early in pregnancy. As more medical professionals and expecting parents become aware of the advantages of NIPT, it has emerged as a favored screening method, particularly for those who are more vulnerable because of advanced maternal age or a family history of genetic abnormalities. Therefore, the necessity for sophisticated, non-invasive testing like NIPT to promote improved prenatal care has increased due to the growing frequency of chromosomal disorders. Challenges in the Saudi Arabia Non-Invasive Prenatal Testing MarketLimited Awareness and Knowledge In Saudi Arabia, a major obstacle is the lack of knowledge and comprehension regarding non-invasive prenatal testing (NIPT). The goal, advantages, and limits of NIPT are not well known to many expectant mothers. According to a poll done between December 2023 and February 2024, 93.3% of respondents gave inaccurate answers to knowledge-related questions, while 64.6% of respondents were not aware of NIPT. Many women may not think of NIPT as a good choice for prenatal screening because of this ignorance, which can lead to poor decision-making. Lack of awareness may prevent pregnant moms from completely appreciating the advantages of NIPT, such as its accuracy in identifying genetic disorders and non-invasive nature, which ultimately restricts its population acceptance. High Cost and Limited Insurance Coverage One of the biggest problems in Saudi Arabia is the high expense of non-invasive prenatal testing (NIPT). Although NIPT has advantages over conventional invasive testing, many pregnant women cannot afford it since it is frequently not covered by insurance. According to research, just 30% of participants were prepared to spend 1,500 SAR (about $400 USD), whereas 74.1% of participants would be willing to undergo NIPT if it were free. Access to NIPT is restricted by this cost burden, especially for those with lower incomes. Because of this, a lot of women could choose more risky or less accurate screening techniques, which would further exacerbate the disparity in access to high-quality prenatal care. Key Attributes Report Attribute Details No. of Pages 200 Forecast Period 2024-2033 Estimated Market Value (USD) in 2024 $46.3 Million Forecasted Market Value (USD) by 2033 $143.1 Million Compound Annual Growth Rate 13.3% Regions Covered Saudi Arabia Key Topics Covered1. Introduction2. Research Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Saudi Arabia Non-Invasive Prenatal Testing Market6. Market Share Analysis6.1 Component6.2 Application6.3 End User7. Component7.1 Instruments7.2 Kits and Reagents7.3 Services8. Application8.1 Down Syndrome (Trisomy 21)8.2 Edwards Syndrome (Trisomy 18)8.3 Patau Syndrome (Trisomy 13)8.4 Turner Syndrome8.5 Other Applications9. End User9.1 Hospitals9.2 Diagnostic Labs10. Porter's Five Analysis10.1 Bargaining Power of Buyers10.2 Bargaining Power of Suppliers10.3 Degree of Rivalry10.4 Threat of New Entrants10.5 Threat of Substitutes11. SWOT Analysis11.1 Strength11.2 Weakness11.3 Opportunity11.4 Threat12. Key Players Analysis12.1 Eurofins Scientific12.2 F. Hoffmann-La Roche Ltd.12.3 Invitae Corporation12.4 Illumina Inc.12.5 Natera Inc.12.6 Centogene N.V.12.7 QiagenFor more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Saudi Arabian Non-Invasive Prenatal Testing Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
2 days ago
- Yahoo
Family of 19-Year-Old Grace Schara takes hospital to court in landmark wrongful death case
APPLETON, Wis. (WFRV) – In a case that has captivated the community and raised profound questions about medical ethics, the trial concerning the wrongful death of 19-year-old Grace Schara commenced on Tuesday in Outagamie County court. The young woman, who had Down syndrome, died at Ascension St. Elizabeth Hospital in Appleton in 2021 after contracting COVID-19. The Schara family has launched a civil lawsuit against the hospital, alleging medical negligence, violations of informed consent, and battery. Wisconsin DNR: Limit time outside due to Canadian wildfire smoke As opening statements unfolded Tuesday morning, the parents of Grace argued that their daughter was administered a combination of medications—precedex, lorazepam, and morphine—without their knowledge or consent. They contend that these drugs, rather than complications from COVID-19, led to Grace's respiratory distress and ultimately her untimely death. The family only discovered a 'Do Not Resuscitate' (DNR) order had been placed on Grace's chart when she was already in critical condition, prompting concerns that medical staff had failed to honor their last-minute request to change her DNR status. The case marks a significant moment in legal history, as it is the first to challenge the designation of COVID-19 as the primary cause of death on a death certificate. The hospital, however, has firmly denied the allegations, asserting that Grace received appropriate care from a team of medical professionals and that her deterioration was a natural progression of her illness. 'Nothing is urgent enough to destroy their life': Sheriff in Wisconsin catches driver going 105 mph in a 55 zone During the trial, plaintiff attorney Warner Mendenhall emphasized the alarming sequence of events leading to Grace's decline, stating, 'Instead of recognizing the life-threatening situation and reducing the medications causing the problems, this medical team did the opposite.' In contrast, defense attorney Jason John Franckowiak argued that the claims are based on misunderstandings surrounding Grace's care, asserting that the medical team acted within the accepted standard of care. Defense attorney Randall also addressed the court, saying, 'We believe the evidence will show that Dr. Shokar's care and treatment of Grace Schara on October 12th and 13th of 2021, met the standard of care that applied.' The emotional weight of the trial is compounded by the heartbreaking testimony from Grace's mother, Cindy Schara, who recalled her daughter's vibrant spirit and artistic talents. 'She was so talented when it came to coloring, and she loved to leave notes for people,' Cindy reflected. 'She learned how to play violin, she was a dancer, she was an actor, she loved to be in plays, our home-schooled plays.' Wisconsin Department of Transportation warning residents of fake DMV link scams As the trial unfolds, it is expected to last up to 3 weeks, drawing attention to critical issues surrounding informed consent and the rights of patients and their families in the healthcare system. The outcome of this landmark case could have far-reaching implications for how medical decisions are made, especially during a public health crisis. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
